17834-02-5,MFCD00272665
Catalog No.:AA0025W9

17834-02-5 | 2H-1-Benzopyran-2-one, 4,6-dihydroxy-3-(3-oxo-1-phenylbutyl)-

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥98%
in stock  
$128.00   $89.00
- +
5mg
≥98%
in stock  
$463.00   $324.00
- +
10mg
≥98%
in stock  
$792.00   $554.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA0025W9
Chemical Name:
2H-1-Benzopyran-2-one, 4,6-dihydroxy-3-(3-oxo-1-phenylbutyl)-
CAS Number:
17834-02-5
Molecular Formula:
C19H16O5
Molecular Weight:
324.3273
MDL Number:
MFCD00272665
SMILES:
CC(=O)CC(c1c(=O)oc2c(c1O)cc(cc2)O)c1ccccc1
Properties
Computed Properties
 
Complexity:
532  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
24  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
4  
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0  
XLogP3:
2.3  

Literature

Title: Warfarin is an effective modifier of multiple UDP-glucuronosyltransferase enzymes: evaluation of its potential to alter the pharmacokinetics of zidovudine.

Journal: Journal of pharmaceutical sciences 20150101

Title: The population pharmacokinetics of R- and S-warfarin: effect of genetic and clinical factors.

Journal: British journal of clinical pharmacology 20120101

Title: Analysis of R- and S-hydroxywarfarin glucuronidation catalyzed by human liver microsomes and recombinant UDP-glucuronosyltransferases.

Journal: The Journal of pharmacology and experimental therapeutics 20120101

Title: Hydroxywarfarin metabolites potently inhibit CYP2C9 metabolism of S-warfarin.

Journal: Chemical research in toxicology 20100517

Title: Assessing cytochrome P450 and UDP-glucuronosyltransferase contributions to warfarin metabolism in humans.

Journal: Chemical research in toxicology 20090701

Title: Identification of hydroxywarfarin binding site in human UDP glucuronosyltransferase 1a10: phenylalanine90 is crucial for the glucuronidation of 6- and 7-hydroxywarfarin but not 8-hydroxywarfarin.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20081101

Title: Synthesis and structure-activity relationships of novel warfarin derivatives.

Journal: Bioorganic & medicinal chemistry 20070315

Title: Determination of warfarin enantiomers and hydroxylated metabolites in human blood plasma by liquid chromatography with achiral and chiral separation.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050425

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:17834-02-5 Molecular Formula|17834-02-5 MDL|17834-02-5 SMILES|17834-02-5 2H-1-Benzopyran-2-one, 4,6-dihydroxy-3-(3-oxo-1-phenylbutyl)-
Catalog No.: AA0025W9
17834-02-5,MFCD00272665
17834-02-5 | 2H-1-Benzopyran-2-one, 4,6-dihydroxy-3-(3-oxo-1-phenylbutyl)-
Pack Size: 1mg
Purity: ≥98%
in stock
$128.00 $89.00
Pack Size: 5mg
Purity: ≥98%
in stock
$463.00 $324.00
Pack Size: 10mg
Purity: ≥98%
in stock
$792.00 $554.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA0025W9
Chemical Name: 2H-1-Benzopyran-2-one, 4,6-dihydroxy-3-(3-oxo-1-phenylbutyl)-
CAS Number: 17834-02-5
Molecular Formula: C19H16O5
Molecular Weight: 324.3273
MDL Number: MFCD00272665
SMILES: CC(=O)CC(c1c(=O)oc2c(c1O)cc(cc2)O)c1ccccc1
Properties
Complexity: 532  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 24  
Hydrogen Bond Acceptor Count: 5  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 4  
Undefined Atom Stereocenter Count: 1  
Undefined Bond Stereocenter Count: 0  
XLogP3: 2.3  
Literature fold

Title: Warfarin is an effective modifier of multiple UDP-glucuronosyltransferase enzymes: evaluation of its potential to alter the pharmacokinetics of zidovudine.

Journal: Journal of pharmaceutical sciences20150101

Title: The population pharmacokinetics of R- and S-warfarin: effect of genetic and clinical factors.

Journal: British journal of clinical pharmacology20120101

Title: Analysis of R- and S-hydroxywarfarin glucuronidation catalyzed by human liver microsomes and recombinant UDP-glucuronosyltransferases.

Journal: The Journal of pharmacology and experimental therapeutics20120101

Title: Hydroxywarfarin metabolites potently inhibit CYP2C9 metabolism of S-warfarin.

Journal: Chemical research in toxicology20100517

Title: Assessing cytochrome P450 and UDP-glucuronosyltransferase contributions to warfarin metabolism in humans.

Journal: Chemical research in toxicology20090701

Title: Identification of hydroxywarfarin binding site in human UDP glucuronosyltransferase 1a10: phenylalanine90 is crucial for the glucuronidation of 6- and 7-hydroxywarfarin but not 8-hydroxywarfarin.

Journal: Drug metabolism and disposition: the biological fate of chemicals20081101

Title: Synthesis and structure-activity relationships of novel warfarin derivatives.

Journal: Bioorganic & medicinal chemistry20070315

Title: Determination of warfarin enantiomers and hydroxylated metabolites in human blood plasma by liquid chromatography with achiral and chiral separation.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences20050425

Building Blocks More >
61826-55-9
61826-55-9
Cyclobutaneacetic acid, 3-acetyl-2,2-dimethyl-, (1R,3R)-rel-
AA002684 | MFCD00001327
179057-20-6
179057-20-6
(3-(1H-Tetrazol-5-yl)phenyl)methanol
AA0026NT | MFCD09864536
179388-65-9
179388-65-9
1-Piperidinepropanol, α-[([1,1'-biphenyl]-2-yloxy)methyl]-γ-imino-, hydrochloride (1:1)
AA0026WX | MFCD03093187
17969-48-1
17969-48-1
2-[4-(4-Chlorophenyl)-1,3-thiazol-2-yl]acetonitrile
AA00274N | MFCD00052875
1833-51-8
1833-51-8
Chloromethyldimethylphenylsilane
AA0027ES | MFCD00040858
201810-59-5
201810-59-5
1'-(tert-Butoxycarbonyl)-1,4'-bipiperidine-4-carboxylic acid
AA0027S6 | MFCD06408960
2023-48-5
2023-48-5
Triphenylbismuth difluoride
AA00283Q | MFCD00092699
202865-72-3
202865-72-3
1-Bromo-4-fluoro-2-iodobenzene
AA0028FM | MFCD00042578
203302-90-3
203302-90-3
Butane, 4-bromo-1,1,1-trifluoro-3-methyl-
AA0028PL | MFCD00190632
203626-57-7
203626-57-7
5,8-Dimethyl-4-hydroxyquinoline
AA0028YT | MFCD00272456
Submit
© 2017 AA BLOCKS, INC. All rights reserved.